Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications

Details for Australian Patent Application No. 2002350604 (hide)

Owner DRUG INNOVATION AND DESIGN, INCORPORATED

Inventors Glazier, Arnold

Agent Spruson & Ferguson

Pub. Number AU-A-2002350604

PCT Number PCT/US02/20279

PCT Pub. Number WO2003/000201

Priority 60/300,805 25.06.01 US

Filing date 24 June 2002

Wipo publication date 8 January 2003

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/300,805 25.06.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002350604

15 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002350605-MANUFACTURE OF ALPHATOCOPHEROL

2002350603-Derivatives of 4-(thioor selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht?2b? receptor antagonist